Vireo Growth Surges on Q4 Revenue Jump and Aggressive Cannabis Deal Pipeline
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vireo Growth ( (TSE:VREO) ) has issued an announcement.
Vireo Growth Inc. reported fourth-quarter 2025 GAAP revenue of $104.5 million, up 317.7% year over year, with gross profit and adjusted EBITDA climbing sharply as recent acquisitions fueled a 22% increase in same-store sales and a 55% jump in wholesale revenue on a pro forma basis. The company ended the quarter with $122.5 million in cash and is extending its acquisition-led growth strategy with pending deals for Eaze, Schwazze and PharmaCann retail assets in Colorado and a nonbinding MOU to acquire Hawthorne, moves that would significantly broaden its retail footprint, digital reach and ancillary capabilities in the cannabis market if completed.
More about Vireo Growth
Vireo Growth Inc. is a U.S.-based cannabis company that operates dispensaries and wholesale operations, with a focus on both retail and same-store sales growth. Listed on the CSE and OTCQX, the company has been expanding through mergers and acquisitions, integrating assets such as Deep Roots, Proper, and Wholesome to build scale across key regulated markets.
Average Trading Volume: 58,485
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$617.4M
For detailed information about VREO stock, go to TipRanks’ Stock Analysis page.
